ONWD.BR Stock - Onward Medical N.V.
Unlock GoAI Insights for ONWD.BR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $77,000 | $532,000 | $2.15M | $1.40M | $800,000 |
| Gross Profit | $-843,000 | $-14,818,000 | $-12,539,000 | $-2,648,000 | $-1,509,000 |
| Gross Margin | -1094.8% | -2785.3% | -583.8% | -189.3% | -188.6% |
| Operating Income | $-36,524,000 | $-35,463,000 | $-32,028,000 | $-28,532,000 | $-15,512,000 |
| Net Income | $-35,725,000 | $-36,181,000 | $-32,772,000 | $-34,314,000 | $-20,014,000 |
| Net Margin | -46396.1% | -6800.9% | -1525.7% | -2452.8% | -2501.8% |
| EPS | $-0.80 | $-1.20 | $-1.09 | $-1.14 | $-0.96 |
Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARCEX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer, which restores or enhances physical movement of hand and arm function to people with spinal cord therapy; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord that enables long-paralyzed people to stand and walk again with little or no assistance. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of ARCEX Therapy in restoring strength and function of upper extremities in people with spinal cord injury. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Visit WebsiteEarnings History & Surprises
ONWD.BREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 2, 2025 | — | $-0.47 | — | — |
Q2 2025 | Apr 1, 2025 | — | $-0.39 | — | — |
Q3 2024 | Aug 6, 2024 | — | $-0.53 | — | — |
Q2 2024 | Apr 25, 2024 | — | $-0.56 | — | — |
Q4 2023 | Nov 16, 2023 | — | $-0.64 | — | — |
Q2 2023 | May 16, 2023 | — | $-0.56 | — | — |
Q3 2022 | Aug 28, 2022 | — | $-0.53 | — | — |
Q2 2022 | Apr 28, 2022 | — | $-1.43 | — | — |
Q4 2021 | Oct 13, 2021 | — | $-3.24 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-2.97 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-2.57 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.32 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.32 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.24 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.24 | — | — |
Latest News
Frequently Asked Questions about ONWD.BR
What is ONWD.BR's current stock price?
What is the analyst price target for ONWD.BR?
What sector is Onward Medical N.V. in?
What is ONWD.BR's market cap?
Does ONWD.BR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ONWD.BR for comparison